🎉 Finosauras is now  SarasRead more
Beta Drugs Ltd logo

Beta Drugs Ltd - Share Price Target 2026

(NSE: BETA)

Sector: Healthcare

Market Cap: 1651.37 Cr

1736.87

-

2034.17

Target Price Range

1550.00

-21.00 (-1.35%)

CMP

Neutral

As on 19 Jan 2026, 03:30 pm

Market Trends

Based on 6 technical indicators.
Bullish2
Bearish2
Neutral2
Agg. Profit Potential21.99%
Agg. Risk 16.37%

Last updated on: 19/01/2026, 3:30 pm

Returns

PeriodReturn %
1 Month-11.08
3 Months-18.42
1 Year-30.83
5 Years1208.02

Last updated on: 04/12/2025, 9:30 AM

Institutional Holdings

InstitutePercentageNo. of Shares
Suryavanshi Commotrade Private Limited6.74%680,026
Bsas Infotech Limited1.27%128,520

Last updated on: 9/30/2025, 12:00:00 AM

Loading technical analysis...

Fundamental Data

Fundamental Analysis

P/E Ratio

107.01

P/B Ratio

12.80

PEG Ratio

-4.20

ROE

12.60%

EPS

15.29

Dividend Yield

N/A

Market Cap

1651.37 Cr

Sector

N/A

Last Updated: 8 Jan 2026, 02:30 pm

Peer Comparison

CompanySentimentTarget PriceUpside

About : Beta Drugs Ltd.

Incorporated Year

2005

City and State

Baddi, Himachal Pradesh

Listing Date

Director's Name

Seema Chopra

Revenue

220.20 Cr

Net Profit

15.43 Cr